Renal implications of percutaneous, coronary intervention

Seminars in Nephrology

Volumn 21, Issue 1, 2001, Pages 36-46

  Korr, Kenneth S ^a   Reitman, Arthur ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; DIATRIZOATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; FIBRINOLYTIC AGENT; IOHEXOL; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; RENOGRAFFIN 76;

AGE; ALGORITHM; ARTICLE; ATHEROSCLEROSIS; BYPASS SURGERY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG CHOICE; HEART CATHETERIZATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

EID: 0035137339     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2001.18375     Document Type: Article

References (57)

1. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease
2. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease
3. Use of conventional and newer radiographic contrast agents in cardiac angiography
4. A comparison of nonionic low osmolarity radiocontrast agents with ionic high osmolarity agents during cardiac catheterization
5. Use of nonionic or low osmolar contrast agents in cardiovascular procedures
6. Effects of ionic and nonionic contrast on in vitro and in vivo platelet activation
7. A hematologist's view of contrast media, clotting in angiography syringes and thrombosis during coronary angiography
8. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction of unstable angina undergoing percutaneous transluminal coronary angioplasty
9. A randomized trial comparing the impact of a nonionic versus an ionic low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty
10. Influence of a nonionic, low-osmolar contrast medium versus an ionic, low osmolar contrast medium on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty
11. Contrast induced nephrotoxicity in patients undergoing cardiac catheterization
12. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization
13. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy
14. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency
15. Risks for renal dysfunction with cardiac angiography
16. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality
17. Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiograohic contrast agent
18. High dose contrast agent administration during complex coronary angioplasty
19. Safety and cost effectiveness of combined coronary angiography and angioplasty
20. Safety and efficacy of percutaneous transluminal coronary angioplasty performed at time of diagnostic catheterization compared with that performed at other times
21. Should interventional cardiac catheterization procedures take place at the time of diagnostic procedures?
22. The effect of acute renal failure on mortality
23. Hospital-acquired renal insufficiency: A prospective study
24. Renal dysfunction after myocardial revascularization: Risk factors, outcomes and hospital resource utilization
25. Contrast media asoociated nephrotoxicity
26. Radiocontrast associated renal dysfunction: Incidence and risk factors
27. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease
28. Nephrotoxicity of high osmolarity vs low osmolality contrast media. Randomized clinical trial
29. Contrast material induced renal failure in patients with diabetes mellitus, renal insufficiency or both
30. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older
31. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography
32. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
33. Radiocontrast induced nephropathy
34. Early renal medullary hypoxic injury from radiocontrast and indomethacin
35. Osmotic nephrosis induced by water soluble triiodinated contrast media in man
36. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat
37. Effects of saline mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents
38. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus
39. Renal functional response to dopamine during and after arteriography in patients with chronic renal insufficiency
40. Use of dopamine in prevention of contrast induced acute renal failure-A randomized study
41. Contrast-induced nephropathy: The effects of vasodilator therapy
42. Fenoldopam: A dopamine type 1 receptor agonist in the prevention of renal injury associated with the administration of intravascular contrast
43. Prophylactic efficacy of Fenoldopam in radiocontrast nephropathy: A randomized, double-blind, placebo-controlled trial
44. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients
45. Metformin
46. Guidelines for performing angiography in patients taking metformin
47. Coronary atherosclerosis in soldiers
48. Prevelance and extent of atherosclerosis in adolescents and young adults
49. Atheroembolic renal disease
50. Incidence of atheroembolic renal failure after coronary angiography
51. Cholesterol embolism: Experience with 22 histologically proven cases
52. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction
53. Cholesterol embolism as a complication of left heart catheterization
54. Nephrotoxicity from contrast material in renal insufficiency: Ionic versus nonionic agents
55. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography
56. Contrast nephropathy in patients with impaired renal function: High versus low osmolar media